Potterat Olivier, Wagner Klaus, Gemmecker Gerd, Mack Jürgen, Puder Carsten, Vettermann Regine, Streicher Rüdiger
Boehringer Ingelheim Pharma GmbH and Co. KG, Birkendorfer Strasse 65, D-88397 Biberach an der Riss, Germany.
J Nat Prod. 2004 Sep;67(9):1528-31. doi: 10.1021/np040093o.
A new bicyclic 19-peptide, BI-32169, has been isolated from the culture broth of Streptomyces sp. (DSM 14996). Its structure has been established by amino acid analysis, mass spectrometry, and 2D NMR analysis. BI-32169 consists exclusively of protein amino acids and is cyclized from the side chain of Asp(9) to the N-terminus of Gly(1). One disulfide bond between Cys(6) and Cys(19) forms a bicyclic structure. BI-32169 and its methyl ester derivative showed potent inhibitory activity against the human glucagon receptor (IC(50) 440 and 320 nM, respectively) in a functional cell-based assay.
一种新的双环19肽BI-32169已从链霉菌属(DSM 14996)的培养液中分离出来。其结构已通过氨基酸分析、质谱和二维核磁共振分析得以确定。BI-32169仅由蛋白质氨基酸组成,并且从Asp(9)的侧链环化至Gly(1)的N端。Cys(6)和Cys(19)之间的一个二硫键形成双环结构。在基于细胞功能的检测中,BI-32169及其甲酯衍生物对人胰高血糖素受体显示出强效抑制活性(IC(50)分别为440和320 nM)。